Loading...

Stock Performance

Data Provided by Refinitiv. Minimum 15 minutes delayed.


蜂窝加速器npv-快连加速器app

July 31, 2024 - Apellis Pharmaceuticals Reports Second Quarter 2024 Financial Results July 7, 2024 - Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA) July 2, 2024 - Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

蜂窝加速器npv-快连加速器app

蜂窝加速器npv-快连加速器app

Investor Relations:
Argot Partners
Sam Martin / Maghan Meyers
(212) 600-1902
Email: sam@argotpartners.com / maghan@argotpartners.com

Media Relations:
Tracy Vineis
(617) 420-4839
Email: media@apellis.com

蜂窝加速器npv-快连加速器app

Sign up to receive email alerts whenever Apellis Pharmaceuticals, Inc. posts new information to the site. Just enter your email address and click Submit.

Sign Up
加速网络连接 Email Alerts RSS Feeds Contact IR
测速网在线测网速  如何从油管下载视频  威伯斯云  chatgpt官网ht//beta.openai.com/examples  快连加速器免费,快连加速器app,快连外网加速器,免费加速器  一元机场,一元com,一元机场art,一元机场入口,一元机场官网